Cargando…

Thrombocytopenia with Absent Radii (TAR) Syndrome Without Significant Thrombocytopenia

Thrombocytopenia with absent radii (TAR) syndrome is a rare genetic syndrome that occurs with a frequency of about 0.42 cases per 100,000 live births. It is characterized by hypo-megakaryocytic thrombocytopenia with bilateral absent radii and the presence of both thumbs. The thrombocytopenia is init...

Descripción completa

Detalles Bibliográficos
Autores principales: Cowan, Jael, Parikh, Taral, Waghela, Rajdeepsingh, Mora, Ricardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575318/
https://www.ncbi.nlm.nih.gov/pubmed/33101804
http://dx.doi.org/10.7759/cureus.10557
_version_ 1783597786567016448
author Cowan, Jael
Parikh, Taral
Waghela, Rajdeepsingh
Mora, Ricardo
author_facet Cowan, Jael
Parikh, Taral
Waghela, Rajdeepsingh
Mora, Ricardo
author_sort Cowan, Jael
collection PubMed
description Thrombocytopenia with absent radii (TAR) syndrome is a rare genetic syndrome that occurs with a frequency of about 0.42 cases per 100,000 live births. It is characterized by hypo-megakaryocytic thrombocytopenia with bilateral absent radii and the presence of both thumbs. The thrombocytopenia is initially very severe, manifesting in the first few weeks to months of life, but subsequently improves with time to reach near normal values by one to two years of age. We present a case of a newborn with TAR syndrome with an atypical presentation of mild thrombocytopenia in the first week of life, with early normalization of platelet counts in the neonatal period. The patient deviates from the normal pattern in which 95% of patients with TAR syndrome usually develop significant thrombocytopenia (platelet counts of less than 50 x 10 (9 )platelets/L) within the first four months of life. Additionally, the absence of hypo-megakaryocytes on peripheral smear sets this patient apart from the typical cases of TAR syndrome. TAR syndrome is often associated with significant morbidity and mortality secondary to severe thrombocytopenia, which occurs with the highest frequency in the first 14 months of life. The most common cause of mortality is due to a severe hemorrhagic event occurring in the brain, gastrointestinal tract, and other organs. Therefore, all patients with TAR syndrome should be monitored closely for symptomatic thrombocytopenia with platelet transfusions being implemented as the first-line therapy for the treatment of severe or symptomatic disease.
format Online
Article
Text
id pubmed-7575318
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-75753182020-10-22 Thrombocytopenia with Absent Radii (TAR) Syndrome Without Significant Thrombocytopenia Cowan, Jael Parikh, Taral Waghela, Rajdeepsingh Mora, Ricardo Cureus Genetics Thrombocytopenia with absent radii (TAR) syndrome is a rare genetic syndrome that occurs with a frequency of about 0.42 cases per 100,000 live births. It is characterized by hypo-megakaryocytic thrombocytopenia with bilateral absent radii and the presence of both thumbs. The thrombocytopenia is initially very severe, manifesting in the first few weeks to months of life, but subsequently improves with time to reach near normal values by one to two years of age. We present a case of a newborn with TAR syndrome with an atypical presentation of mild thrombocytopenia in the first week of life, with early normalization of platelet counts in the neonatal period. The patient deviates from the normal pattern in which 95% of patients with TAR syndrome usually develop significant thrombocytopenia (platelet counts of less than 50 x 10 (9 )platelets/L) within the first four months of life. Additionally, the absence of hypo-megakaryocytes on peripheral smear sets this patient apart from the typical cases of TAR syndrome. TAR syndrome is often associated with significant morbidity and mortality secondary to severe thrombocytopenia, which occurs with the highest frequency in the first 14 months of life. The most common cause of mortality is due to a severe hemorrhagic event occurring in the brain, gastrointestinal tract, and other organs. Therefore, all patients with TAR syndrome should be monitored closely for symptomatic thrombocytopenia with platelet transfusions being implemented as the first-line therapy for the treatment of severe or symptomatic disease. Cureus 2020-09-20 /pmc/articles/PMC7575318/ /pubmed/33101804 http://dx.doi.org/10.7759/cureus.10557 Text en Copyright © 2020, Cowan et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Genetics
Cowan, Jael
Parikh, Taral
Waghela, Rajdeepsingh
Mora, Ricardo
Thrombocytopenia with Absent Radii (TAR) Syndrome Without Significant Thrombocytopenia
title Thrombocytopenia with Absent Radii (TAR) Syndrome Without Significant Thrombocytopenia
title_full Thrombocytopenia with Absent Radii (TAR) Syndrome Without Significant Thrombocytopenia
title_fullStr Thrombocytopenia with Absent Radii (TAR) Syndrome Without Significant Thrombocytopenia
title_full_unstemmed Thrombocytopenia with Absent Radii (TAR) Syndrome Without Significant Thrombocytopenia
title_short Thrombocytopenia with Absent Radii (TAR) Syndrome Without Significant Thrombocytopenia
title_sort thrombocytopenia with absent radii (tar) syndrome without significant thrombocytopenia
topic Genetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575318/
https://www.ncbi.nlm.nih.gov/pubmed/33101804
http://dx.doi.org/10.7759/cureus.10557
work_keys_str_mv AT cowanjael thrombocytopeniawithabsentradiitarsyndromewithoutsignificantthrombocytopenia
AT parikhtaral thrombocytopeniawithabsentradiitarsyndromewithoutsignificantthrombocytopenia
AT waghelarajdeepsingh thrombocytopeniawithabsentradiitarsyndromewithoutsignificantthrombocytopenia
AT moraricardo thrombocytopeniawithabsentradiitarsyndromewithoutsignificantthrombocytopenia